VC Portfolio Analysis Calculator

🚀 VC Portfolio Analysis Calculator

Professional-grade venture capital portfolio modeling and education platform

📈 Portfolio Parameters

📊 Portfolio Performance

Expected Multiple

-

Portfolio IRR

-

Break-Even Hit Rate

-

Required Win Multiple

-

📋 Quick Interpretation

Run the calculator to see personalized insights...

🎯 Understanding Venture Capital Returns

Venture capital is fundamentally different from traditional investing. Success depends on a few massive winners compensating for many failures - this is called the "Power Law" of VC returns.

💰 What is a "Win Multiple"?

A multiple shows how much money you get back compared to your investment:

  • 2x: $100K → $200K (doubled)
  • 10x: $100K → $1M (great return)
  • 100x: $100K → $10M (home run)

Real Example: A $250K investment in Facebook's Series A (2005) would be worth ~$200M today - an 800x multiple!

📈 Key Metrics Explained

Expected Multiple: Average return per dollar invested

Portfolio IRR: Annualized return percentage (like compound interest)

Break-Even Hit Rate: Minimum success rate needed to not lose money

Required Win Multiple: How big winners need to be given your failure rate

🎲 Monte Carlo Simulation

This runs 1,000+ random scenarios of your portfolio to show the range of possible outcomes. VC returns are highly variable - you might get lucky or unlucky.

10th Percentile (Worst Case)

90% chance you'll do better than this

50th Percentile (Median)

Most likely outcome

90th Percentile (Best Case)

10% chance of doing this well

🏥 MedTech Investment Stages & Success Rates

Medical technology investments have unique risk profiles at different stages due to regulatory requirements, clinical trials, and FDA approval processes.

Stage Typical Failure Rate Expected Multiple (Winners) Key Risks Time to Exit
Pre-Clinical 85-95% 20-100x Technology validation, IP 8-12 years
Clinical Stage (Phase I/II) 75-85% 10-50x Clinical trials, FDA approval 6-10 years
Late Clinical (Phase III) 60-75% 5-25x Regulatory approval, market access 4-8 years
Commercial Stage 40-60% 3-15x Market adoption, competition 3-6 years
Digital Health/SaaS 65-80% 5-30x Regulatory (if applicable), adoption 5-8 years

⚠️ MedTech Reality Check

Medical technology investments often take 2-3x longer and require 2-3x more capital than initially projected. Factor in:

  • FDA approval delays and requirement changes
  • Clinical trial recruitment challenges
  • Reimbursement and health system adoption hurdles
  • Need for follow-on capital throughout development

⚡ The Power Law of VC Returns

In a typical VC portfolio, returns follow a highly skewed distribution where a small number of investments drive almost all returns.

📊 Typical VC Fund Breakdown

  • 1 company: Returns 10-100x (fund maker)
  • 2-3 companies: Return 3-10x (solid wins)
  • 3-5 companies: Return 1-3x (modest success)
  • 5-10 companies: Return 0.1-1x (disappointing)
  • 10+ companies: Total loss (failures)

💡 What This Means for You

  • You need access to potential "grand slams"
  • Portfolio size matters for diversification
  • Can't predict which deals will be winners
  • Follow-on capital is crucial for winners
  • Time horizon must be 7-10+ years

🎯 Key Insight

The goal isn't to minimize failures - it's to maximize your exposure to potential massive winners while maintaining enough diversification to capture them.

🚨 Common Mistakes & Reality Checks

❌ What Doesn't Work

  • Trying to pick only "safe" deals
  • Insufficient portfolio diversification
  • No reserves for follow-on investments
  • Unrealistic timeline expectations
  • Ignoring the power law dynamics

✅ What Works

  • Focus on market size and potential
  • Bet on exceptional teams
  • Maintain disciplined portfolio construction
  • Reserve capital for follow-ons
  • Take a long-term view (10+ years)

🏆 Top-Tier VC Performance Standards

Understanding what elite venture capital firms like Andreessen Horowitz, Sequoia, and Benchmark achieve helps set realistic expectations and goals.

📊 Fund-Level Performance

Top Decile VC 25-40% IRR
Upper Quartile 15-25% IRR
Median VC 10-15% IRR
Bottom Quartile 0-10% IRR

🎯 Deal-Level Expectations

  • Minimum viable return: 10x in 7-10 years
  • Market size threshold: $10B+ TAM
  • Ownership target: 15-25% fully diluted
  • Growth expectations: 100%+ YoY (early stage)
  • Category creation: Preference for new markets

💼 Portfolio Construction Strategies

Andreessen Horowitz Approach

  • 30-40 companies per fund
  • Initial check: $1-10M
  • Reserve 2-3x initial for follow-ons
  • Concentrated bets on winners
  • Sector-focused expertise

Sequoia Capital Approach

  • 20-25 companies per fund
  • Higher initial ownership targets
  • Strong follow-on discipline
  • Long-term partnership model
  • Board-level involvement

📈 Stage-Specific Benchmarks

Investment Stage Typical Check Size Expected Multiple Target IRR Time Horizon Failure Rate
Pre-Seed $100K - $500K 25-100x 40-60% 8-12 years 90-95%
Seed $500K - $2M 15-50x 30-45% 7-10 years 85-90%
Series A $3M - $15M 10-30x 25-35% 6-9 years 75-85%
Series B $10M - $30M 5-20x 20-30% 5-8 years 65-75%
Growth/Late $25M - $100M+ 3-10x 15-25% 3-6 years 50-65%

🔥 Sector-Specific Performance

Different sectors have varying risk-return profiles and success rates based on market dynamics, regulatory requirements, and capital intensity.

🧬 Biotech/Pharma

  • Success Rate: 5-15%
  • Winner Multiples: 10-1000x
  • Time to Exit: 10-15 years
  • Capital Intensity: Very High

🏥 MedTech/Devices

  • Success Rate: 15-30%
  • Winner Multiples: 5-50x
  • Time to Exit: 7-12 years
  • Capital Intensity: High

💻 Software/SaaS

  • Success Rate: 20-35%
  • Winner Multiples: 5-100x
  • Time to Exit: 5-8 years
  • Capital Intensity: Medium

🔋 Cleantech/Energy

  • Success Rate: 10-25%
  • Winner Multiples: 3-30x
  • Time to Exit: 8-12 years
  • Capital Intensity: Very High

🚨 The Harsh Reality

Most individual investors and smaller funds cannot achieve top-tier VC returns because:

  • Deal Access: Best opportunities go to established funds first
  • Check Size: Can't write large enough checks for meaningful ownership
  • Due Diligence: Lack resources for proper evaluation
  • Follow-on Capital: Can't participate in subsequent rounds
  • Portfolio Support: Limited ability to help companies succeed

Recommendation: Be conservative with assumptions and realistic about your competitive position in the market.